Huber, M A

Successful prevention of recurrent nasal polyposis by means of systemic low-dose IFN-alpha2a. [electronic resource] - The Journal of allergy and clinical immunology Jul 2001 - 141 p. digital

Publication Type: Case Reports; Letter

0091-6749

10.1067/mai.2001.116288 doi


Female
Humans
Interferon alpha-2
Interferon-alpha--administration & dosage
Male
Middle Aged
Nasal Polyps--prevention & control
Recombinant Proteins
Recurrence